Life Science REIT plc (LABS.L) LSE
43.10
+1.7(+4.11%)
Currency In GBp
- General
- Statistics
- Historical Data
- Profile
- Financials
43.10
+1.7(+4.11%)
Currency In GBp
| Market Cap | 133M |
| Enterprise Value | 249.67M |
| P/E Ratio | -4.92 |
| PEG Ratio | -0.05 |
| Price/Sales Ratio | 7.17 |
| Price/Book Ratio | 0.65 |
| Enterprise/Revenue | 12.95 |
| Enterprise/EBITDA | 29.74 |
| Fiscal Year | December 31, 2024 |
| Most Recent Quarter | June 30, 2025 |
| Profit Margin | -1.46 |
| Operating Margin | 0.44 |
| Return On Assets | -0.08 |
| Return On Equity | -0.12 |
| Revenue | 20.31M |
| Revenue/Share | 0.06 |
| Gross Profit | 11.45M |
| EBITDA | 9.78M |
| Net Income | -13.98M |
| Diluted EPS | -0.04 |
| Total Cash | 4.72M |
| Total Cash/Share | 0.01 |
| Total Debt | 126.4M |
| Total Debt/Equity | 0.54 |
| Current Ratio | 0 |
| Book Value Per Share | 0.67 |
| 52-Week Change | -3.79 |
| 52-Week High | 49 |
| 52-Week Low | 34 |
| Moving Average 50 Days | 40.87 |
| Moving Average 200 Days | 39.3 |
| Average Volume | 4.73M |
| Shares Outstanding | 350M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0.33 |
| Payout Ratio | -0.11 |
| Last Split Factor | N/A |
| Last Split Date | N/A |